Actualité

New issue of Instituto Bernabeu corporate newsletter (IB NEWSLETTER) on the 2^nd International Meeting of Experts on Reproductive Medicine "MEETING THE EXPERTS" which will be held on the 30^th September the 1^st October  at Instituto Bernabeu of Alicante Auditorium.

The scientific committee of therecent European Human Genetics Conference which took place in Barcelona last May accepted the research work entitled “Relevance of SNP on p53, IL-11, IL-10, VEGF and APOE in patients with repeated implantation failure (RIF) and pregnancy loss (RPL)”.

In the Spanish Fertility Society Congress in Malaga between the 19th and 21st May, Dr Belén Lledó will give an oral presentation on research work entitled 'Recombinant or urinary FSH? Is receptor genotype key when choosing the FSH?'

Dr Rafeal Bernabeu has been named director of the professorship by the university chancellor. The aim is to promote training and research as well as the development and dissemination of the subject matter.

There is increasing evidence to suggest an impact on endometrial receptivity during ovarian stimulation due, in part, to accelerated endometrial maturity leading to endometrium-embryo asynchrony. 

The new Instituto Bernabeu newsletter is now available, dedicated to creation of the first thermal gel "Incubator" that keeps the embryo temperature for the transfer.

Rafael Bernabeu Charitable Work Foundation has delivered this morning's scholarship of training and paid work to highlight student of the fifth edition of the Master of Reproductive Medicine organized by the University of Alicante and Instituto Bernabeu. 

Implantation failure is one of reproductive medicine's biggest challenges and it is for this reason that our unit which specialises in its treatment is working on and researching new approaches. One of the new lines of research include approaches in order to reduce uterine contractuality so that embryo acceptance is facilitated during transfer.

Our unit for the treatment of implantation failure and recurrent pregnancy loss is constantly working on new means of improving both diagnosis and treatment. One of the lines of work centres around the impact of a particular endometriosis variant known as adenomyosis.

The rate of embryonic aneuploidy is mainly associated with either maternal or paternal-related factors. Various studies have shown that maternal age is a key factor in the incidence of embryonic aneuploidy